Michael D Jensen1. 1. Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA. jensen@mayo.edu
Abstract
CONTEXT: An upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk. EVIDENCE ACQUISITION: The measured functions of different fat depots with regards to fatty acid storage and release in health and obesity were reviewed. The adverse effects of experimentally increasing free fatty acid (FFA) concentrations on liver, muscle, pancreatic beta-cell, and endothelial function were noted. EVIDENCE SYNTHESIS: The most dramatic abnormality in FFA metabolism is failure to suppress FFA concentrations/adipose tissue lipolysis normally in response to postprandial hyperinsulinemia. Upper body sc fat delivers the majority of FFA to the systemic circulation under postabsorptive and postprandial conditions. In upper body obesity, portal FFA concentrations resulting from both systemic and visceral adipose tissue lipolysis may be significantly greater than arterial FFA concentrations, exposing the liver to even greater amounts of FFA. Visceral fat also releases sufficient IL-6 to increase portal vein IL-6 concentrations, which can affect hepatic metabolism as well. CONCLUSIONS: Lower body, upper body sc, and visceral fat depots have unique characteristics with regards to fatty acid metabolism. Selective dysregulation of these depots probably plays an important role with the metabolic complications of obesity.
CONTEXT: An upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk. EVIDENCE ACQUISITION: The measured functions of different fat depots with regards to fatty acid storage and release in health and obesity were reviewed. The adverse effects of experimentally increasing free fatty acid (FFA) concentrations on liver, muscle, pancreatic beta-cell, and endothelial function were noted. EVIDENCE SYNTHESIS: The most dramatic abnormality in FFA metabolism is failure to suppress FFA concentrations/adipose tissue lipolysis normally in response to postprandial hyperinsulinemia. Upper body sc fat delivers the majority of FFA to the systemic circulation under postabsorptive and postprandial conditions. In upper body obesity, portal FFA concentrations resulting from both systemic and visceral adipose tissue lipolysis may be significantly greater than arterial FFA concentrations, exposing the liver to even greater amounts of FFA. Visceral fat also releases sufficient IL-6 to increase portal vein IL-6 concentrations, which can affect hepatic metabolism as well. CONCLUSIONS: Lower body, upper body sc, and visceral fat depots have unique characteristics with regards to fatty acid metabolism. Selective dysregulation of these depots probably plays an important role with the metabolic complications of obesity.
Authors: Michael D Jensen; Michael G Sarr; Daniel A Dumesic; Peter A Southorn; James A Levine Journal: Am J Physiol Endocrinol Metab Date: 2003-08-12 Impact factor: 4.310
Authors: Samuel Klein; Luigi Fontana; V Leroy Young; Andrew R Coggan; Charles Kilo; Bruce W Patterson; B Selma Mohammed Journal: N Engl J Med Date: 2004-06-17 Impact factor: 91.245
Authors: Marieke B Snijder; Jacqueline M Dekker; Marjolein Visser; Lex M Bouter; Coen D A Stehouwer; John S Yudkin; Robert J Heine; Giel Nijpels; Jacob C Seidell Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: Lorraine E Levitt Katz; Kevin A Gralewski; Pamela Abrams; Preneet C Brar; Paul R Gallagher; Terri H Lipman; Lee J Brooks; Dorit Koren Journal: Pediatr Diabetes Date: 2014-12-10 Impact factor: 4.866
Authors: Cheryl A Conover; Sara L Harstad; Tamar Tchkonia; James L Kirkland Journal: Am J Physiol Endocrinol Metab Date: 2013-09-17 Impact factor: 4.310